TY  - JOUR
AU  - Ewers, Michael
AU  - Ioannidis, John P A
AU  - Plesnila, Nikolaus
TI  - Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
JO  - Journal of clinical epidemiology
VL  - 130
SN  - 0895-4356
CY  - Amsterdam [u.a.]
PB  - Elsevier Science
M1  - DZNE-2021-00988
SP  - 143 - 146
PY  - 2021
KW  - COVID-19 Drug Treatment
KW  - COVID-19: drug therapy
KW  - COVID-19: mortality
KW  - Clinical Trials as Topic: standards
KW  - Humans
KW  - Hydroxychloroquine: adverse effects
KW  - Hydroxychloroquine: therapeutic use
KW  - Information Dissemination
KW  - Medical Records
KW  - Observational Studies as Topic: standards
KW  - Open Access Publishing
KW  - Survival Analysis
KW  - Time Factors
KW  - Hydroxychloroquine (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:33068714
C2  - pmc:PMC7554475
DO  - DOI:10.1016/j.jclinepi.2020.10.008
UR  - https://pub.dzne.de/record/155828
ER  -